Diamond BioFund Inc.(TW:6901)
NT$14.00+0.25 (+1.82%)
TW:6901
Diamond BioFund Inc. financials statements
NT$14.00
At close:+0.25 (+1.82%)
Diamond BioFund Inc. (6901) Income Statement
Diamond BioFund Inc. Income Statement
Last quarter (Q2 2026), Diamond BioFund Inc.'s total revenue was NT$3.47B, an increase of 922.64% from the same quarter last year. In Q2, Diamond BioFund Inc.'s net income was NT$3.44B. See Diamond BioFund Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ -596.00K | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | |
| NT$ -28.58M | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | |
| NT$ 1.25B | NT$ 180.85M | NT$ 162.23M | NT$ 137.59M | NT$ 102.43M | |
| Depreciation and Amortization | NT$ 27.98M | NT$ 28.58M | NT$ 9.85M | NT$ 11.47M | NT$ 11.86M |
| NT$ -1.14B | NT$ -2.36B | NT$ -2.57B | NT$ 892.83M | NT$ 2.97B | |
| NT$ -1.28B | NT$ -180.85M | NT$ -162.23M | NT$ -137.59M | NT$ -102.43M | |
| NT$ 104.75M | NT$ -2.22B | NT$ -2.42B | NT$ 1.02B | NT$ 3.06B | |
| NT$ -1.17B | NT$ -2.40B | NT$ -2.58B | NT$ 881.12M | NT$ 2.96B | |
| NT$ -1.17B | NT$ -2.52B | NT$ -2.58B | NT$ 797.78M | NT$ 2.85B | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.38 | NT$ -2.96 | NT$ -3.32 | NT$ 1.07 | NT$ 3.01 |
| Diluted EPS | NT$ -1.38 | NT$ -2.96 | NT$ -3.32 | NT$ 1.03 | NT$ 2.98 |
| Weighted Average Shares Outstanding | 851.97M | 850.47M | 778.90M | 749.30M | 948.72M |
| Weighted Average Shares Outstanding (Diluted) | 851.97M | 850.47M | 778.90M | 773.21M | 954.86M |
Currency in TWD

